Mohammad Ramezani

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Medicinal research reviews

Gene therapy

Applied biochemistry and biotechnology

Biomaterials science

Mashhad University of Medical Sciences

Mashhad University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mashhad University of Medical Sciences Feb 01 1990

Iran

Full Professor :: Pharmaceutical Biotechnology, School of Pharmacy

Education History

Mashhad University of Medical Sciences Jan 01 1990

Iran

PHD :: Pharmaceutical Research Center

Publications

Mojtaba Taheri, Hossein Abdul Tehrani, Sadegh Dehghani, Mona Alibolandi, Ehsan Arefian, Mohammad Ramezani
Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off-the-shelf versatile tumor delivery vehicle. Medicinal research reviews 44 (4) (2024)
Mojtaba Taheri, Hossein Abdul Tehrani, Sadegh Dehghani, Mona Alibolandi, Ehsan Arefian, Mohammad Ramezani
Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off-the-shelf versatile tumor delivery vehicle. Medicinal research reviews (2024)
Mojtaba Taheri, Hossein Abdul Tehrani, Sadegh Dehghani, Mona Alibolandi, Ehsan Arefian, Mohammad Ramezani
Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off-the-shelf versatile tumor delivery vehicle. Medicinal research reviews 44 (4) (2024)
Mojtaba Taheri, Hossein Abdul Tehrani, Sadegh Dehghani, Mona Alibolandi, Ehsan Arefian, Mohammad Ramezani
Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off-the-shelf versatile tumor delivery vehicle. Medicinal research reviews 44 (4) (2024)
Mohammad Ramezani, Vladimir P Torchilin, Seyed Mohammad Taghdisi, Khalil Abnous, Mohammad Ramezani, Mona Alibolandi
"Smart" self-assembled structures: toward intelligent dual responsive drug delivery systems. Biomaterials science 8 (21) (2021)
Setareh Sanati, Sahar Taghavi, Khalil Abnous, Seyed Mohammad Taghdisi, Maryam Babaei, Mohammad Ramezani, Mona Alibolandi
Fabrication of anionic dextran-coated micelles for aptamer targeted delivery of camptothecin and survivin-shRNA to colon adenocarcinoma. Gene therapy (2021)
Maryam Afsharzadeh, Khalil Abnous, Rezvan Yazdian-Robati, Armin Ataranzadeh, Mohammad Ramezani, Maryam Hashemi
Formulation and evaluation of anticancer and antiangiogenesis efficiency of PLA-PEG nanoparticles loaded with galbanic acid in C26 colon carcinoma, in vitro and in vivo. Journal of cellular physiology 234 (5) (2018)
Maryam Sadat Nabavinia, Aida Gholoobi, Fahimeh Charbgoo, Mahboobeh Nabavinia, Mohammad Ramezani, Khalil Abnous
Anti-MUC1 aptamer: A potential opportunity for cancer treatment. Medicinal research reviews 37 (6) (2017)
Maryam Sadat Nabavinia, Fahimeh Charbgoo, Mona Alibolandi, Fatemeh Mosaffa, Aida Gholoobi, Mohammad Ramezani, Khalil Abnous
Comparison of Flow Cytometry and ELASA for Screening of Proper Candidate Aptamer in Cell-SELEX Pool. Applied biochemistry and biotechnology 184 (2) (2017)

Mohammad Ramezani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mohammad Ramezani